TABLE 1.
Primers of selected antiviral and inflammatory genes
Primer | Gene | Primer |
Region | Amplicon size (bp) | |
---|---|---|---|---|---|
Orientation | Sequence (5′-3′) | ||||
1 | IL-1β | F | TGG ACC TTC CAG GAT GAG GAC A | 897–1044 | 148 |
R | GTT CAT CTC GGA GCC TGT AGT G | ||||
2 | IL-2 | F | GGA CTT TCT GAG GAG ATG GAT AG | 498–581 | 84 |
R | TGT TGT AAG CAG GAG GTA CAT AG | ||||
3 | IL-6 | F | TAC CAC TTC ACA AGT CGG AGG C | 169–284 | 116 |
R | CTG CAA GTG CAT CAT CGT TGT TC | ||||
4 | IL-12p40 | F | TTG AAC TGG CGT TGG AAG CAC G | 720–851 | 132 |
R | CCA CCT GTG AGT TCT TCA AAG GC | ||||
5 | TNF-α | F | TTG TCT ACT CCC AGG TTC TCT | 526–632 | 107 |
R | GAG GTT GAC TTT CTC CTG GTA TG | ||||
6 | G-CSF | F | GCA GGC TCT ATC GGG TAT TTC | 1895–2006 | 112 |
R | CAC CCC TAG GTT TTC CAT CTG | ||||
7 | MCP-1 | F | GTC CCT GTC ATG CTT CTG G | 92–235 | 144 |
R | GCT CTC CAG CCT ACT CAT TG | ||||
8 | IP-10 | F | ATC ATC CCT GCG AGC CTA TCC T | 223–356 | 134 |
R | GAC CTT TTT TGG CTA AAC GCT TTC | ||||
9 | CXCL-1(KC) | F | TCC AGA GCT TGA AGG TGT TGC C | 206–315 | 110 |
R | AAC CAA GGG AGC TTC AGG GTC A | ||||
10 | MIP-1α | F | ACC ATG ACA CTC TGC AAC C | 141–243 | 103 |
R | CGA TGA ATT GGC GTG GAA TC | ||||
11 | RANTES | F | CCT GCT GCT TTG CCT ACC TCT C | 152–276 | 125 |
R | ACA CAC TTG GCG GTT CCT TCG A | ||||
12 | IFN-β | F | GCG GAC TTC AAG ATC CCT ATG | 183–322 | 140 |
R | ACA ATA GTC TCA TTC CAC CCA G | ||||
13 | IFN-γ | F | AAA TCC TGC AGA GCC AGA TTA T | 299–426 | 128 |
R | GCT GTT GCT GAA GAA GGT AGT A | ||||
14 | MX-1 | F | TGG ACA TTG CTA CCA CAG AGG C | 773–887 | 115 |
R | TTG CCT TCA GCA CCT CTG TCC A |